Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZL31
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,106
Award facts
- Contract value 100% obligated
- $25,106.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. This award, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a routine pharmaceutical supply order without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected to fulfill this delivery requirement through its existing Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid through November 2026.
EXPAREL is a long-acting local anesthetic utilized in surgical and medical settings for pain management. The order will be performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. This delivery order exemplifies the company's ongoing role in supporting military and federal healthcare systems through the DLA's SPE2DB pharmaceutical supply program.
Quick answers
Who was awarded contract SPE2DB25FZL31?
SPE2DB25FZL31 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FZL31 worth?
The government has obligated $25,106 on SPE2DB25FZL31.
Is contract SPE2DB25FZL31 an order under another contract?
Yes. SPE2DB25FZL31 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL31 competed?
The extent of competition for SPE2DB25FZL31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award